BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

941 related articles for article (PubMed ID: 30970294)

  • 41. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA PCGEM1 accelerates non-small cell lung cancer progression via sponging miR-433-3p to upregulate WTAP.
    Weng L; Qiu K; Gao W; Shi C; Shu F
    BMC Pulm Med; 2020 Aug; 20(1):213. PubMed ID: 32787827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
    Song J; Su ZZ; Shen QM
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNA CCAT1 promotes non-small cell lung cancer progression by regulating the miR-216a-5p/RAP2B axis.
    Pang L; Zhang Q; Wu Y; Yang Q; Zhang J; Liu Y; Li R
    Exp Biol Med (Maywood); 2021 Jan; 246(2):142-152. PubMed ID: 33023331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B; Li J; Zheng M; Ge J; Li J; Yu P
    Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
    Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
    Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LINC00632 inhibits the malignant development of non-small cell lung cancer by downregulating miR-1203.
    Luo T; Yan L; Liu H
    J BUON; 2020; 25(3):1517-1524. PubMed ID: 32862599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
    Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
    IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long Noncoding RNA MALAT1 Regulates Hepatocellular Carcinoma Growth Under Hypoxia via Sponging MicroRNA-200a.
    Zhao ZB; Chen F; Bai XF
    Yonsei Med J; 2019 Aug; 60(8):727-734. PubMed ID: 31347327
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis.
    Sun R; Zhang L
    Biomed Pharmacother; 2019 Mar; 111():1036-1045. PubMed ID: 30841417
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-489-3p promotes malignant progression of non-small cell lung cancer through the inactivation of Wnt/β-catenin signaling pathway via regulating USP48.
    Zhang P; Li L; Wang B; Ran X; Yang S; Luo Y; Li Y; Wang Z; Liu Y; Zhu B
    Respir Res; 2022 Apr; 23(1):93. PubMed ID: 35413838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.
    Dong L; Li G; Li Y; Zhu Z
    Med Sci Monit; 2019 Mar; 25():2311-2319. PubMed ID: 30926767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W; Cui Y; Wang D; Wang Y; Wang L
    Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.